Table 3.
Summary of results: systemic corticosteroids perioperatively.
| Name | Author and publication date | Type of study | Number of patients | Investigated drug | Side effects | Conclusions | Quality of evidence | 
|---|---|---|---|---|---|---|---|
| Impact of Preoperative Systemic Corticosteroids on the Histology and Diagnosis of Eosinophilic Chronic Rhinosinusitis [25] | Akiyama 2019 | Case series | 44 | Preoperative oral prednisolone (0.3 mg/kg as a guide). | Not mentioned. | Oral prednisolone did not appear to markedly affect the tissue eosinophil count. | Low | 
| Prospective evaluation of oral corticosteroid as a predictor of postoperative olfactory recovery after functional endoscopic surgery for nasal polyposis [26] | Rives 2019 | Prospective | 119 | Oral prednisolone 1 mg/kg/day for 5 days preoperatively. | Not mentioned. | Olfactory recovery greater than 50% after a course of OCS therapy may be a predictor of better subjective postoperative recovery. | Low | 
| Differential effects of postoperative oral corticosteroid on eosinophilic vs. non-eosinophilic CRSwNP subtypes [27] | Shen 2019 | Randomized controlled trial | 100 | Oral prednisolone (30 mg/day) for 2 weeks after surgery. | No severe side effects. | The subjective parameters, including self-rated nasal health, decreased in both groups over time, but demonstrated no statistically significant differences between the corticosteroid and placebo groups. | Moderate | 
| Effect of steroids for nasal polyposis surgery: A placebo-controlled, randomized, double-blind study [28] | Ecevit 2015 | Randomized controlled trial | 22 | Six pills of 10 mg prednisolone and 90 mg lactose for 7 days, reduced to one pill taken every other day preoperatively. | Not mentioned. | Preoperative administration of systemic corticosteroids improves the perioperative visibility by reducing blood loss and shortens the operation time. | Moderate | 
| Impact of perioperative systemic steroids on surgical outcomes in patients with chronic rhinosinusitis with polyposis: evaluation with the novel Perioperative Sinus Endoscopy (POSE) scoring system [29] | Wright 2007 | Randomized controlled trial | 26 | 30 mg of prednisone for 5 days preoperatively and 9 days postoperatively. | Not mentioned. | Pretreatment with systemic corticosteroids appears to confer the advantages of facilitating surgery and results in endoscopically healthier sinus cavities in the short term. | Moderate | 
| Oral Corticosteroids Following Endoscopic Sinus Surgery for Chronic Rhinosinusitis Without Nasal Polyposis: A Randomized Clinical Trial [30] | Chang 2021 | Randomized controlled trial | 72 | 12-day postoperative taper of oral prednisone: 30 mg, 4 days; 20 mg, 4 days; and 10 mg 4 days. | Not mentioned. | Oral prednisone following endoscopic sinus surgery conferred no additional benefit over placebo. These results suggest that the risks of oral corticosteroids may outweigh the benefits. | Moderate | 
| Lack of additive benefit of oral steroids on short-term postoperative outcomes in nasal polyposis [31] | Arancibia 2020 | Randomized controlled trial | 70 | Postoperative 30 mg of oral prednisone for 1 week, 20 mg for 1 week, 10 mg for 1 week, and finally 5 mg for 1 week. | Not mentioned. | Postoperative OCS as an add-on treatment for CRSwNP patients does not improve sinonasal and QoL outcomes; thus, they should not be routinely recommended. | Moderate |